Pages that link to "Q34140498"
Jump to navigation
Jump to search
The following pages link to Pancreatic adenocarcinoma (Q34140498):
Displaying 50 items.
- Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis (Q26782719) (← links)
- Neoadjuvant therapy for localized pancreatic cancer: guiding principles (Q26799428) (← links)
- Imaging preoperatively for pancreatic adenocarcinoma (Q26799450) (← links)
- Surgical treatment for advanced pancreatic cancer (Q27003396) (← links)
- Molecular Imaging of Pancreatic Cancer with Antibodies (Q30393523) (← links)
- Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation (Q30423279) (← links)
- Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound (Q30465459) (← links)
- Intensity of follow-up after pancreatic cancer resection (Q33791048) (← links)
- Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials (Q33802617) (← links)
- Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression (Q33803923) (← links)
- Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma (Q33905392) (← links)
- High-quality endoscopic ultrasound-guided fine needle aspiration tissue acquisition (Q33970078) (← links)
- Pancreatic cancer-improved care achievable (Q34036659) (← links)
- Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma (Q34048461) (← links)
- Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model (Q35214109) (← links)
- A qualitative study of patient and clinician attitudes regarding surveillance after a resection of pancreatic and peri-ampullary cancer (Q35469061) (← links)
- Improving the results of pancreatic endoscopic ultrasound-guided fine needle aspiration in daily practice: keep it simple (Q35768479) (← links)
- Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy. (Q35890548) (← links)
- Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer (Q36064780) (← links)
- Pancreatic cancer: current standards, research updates and future directions (Q36097184) (← links)
- Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma (Q36151583) (← links)
- Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI). (Q36179711) (← links)
- Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model. (Q36437605) (← links)
- The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients (Q36570306) (← links)
- Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma (Q36626546) (← links)
- Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma (Q36747372) (← links)
- Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer (Q37174939) (← links)
- Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma (Q37322384) (← links)
- Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation (Q37482653) (← links)
- The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma. (Q37710295) (← links)
- Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis (Q37716482) (← links)
- Palliative resections versus palliative bypass procedures in pancreatic cancer—a systematic review (Q37922990) (← links)
- Advanced-stage pancreatic cancer: therapy options (Q38102914) (← links)
- Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy (Q38194961) (← links)
- A case series and literature review of Merkel cell carcinoma metastasizing to pancreas (Q38317279) (← links)
- Pancreatic cancer: diagnosis and treatments (Q38354856) (← links)
- Patient and physician views of shared decision making in cancer. (Q38808591) (← links)
- Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma (Q40180313) (← links)
- Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer (Q40217786) (← links)
- Changing trends in tissue acquisition in malignant pancreatic neoplasms (Q40303365) (← links)
- MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer (Q41672310) (← links)
- Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis (Q43565999) (← links)
- Normalization of CA19-9 following resection for pancreatic ductal adenocarcinoma is not tantamount to being cured? (Q43793317) (← links)
- The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer. (Q44296948) (← links)
- Blinded by the Light: Molecular Imaging in Pancreatic Adenocarcinoma (Q46633320) (← links)
- Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer (Q46689245) (← links)
- Prevalence and outcomes of cystic lesions of the transplant pancreas: The University of Wisconsin Experience (Q47245363) (← links)
- Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma (Q48156217) (← links)
- Serum carbohydrate antigen 19-9 in pancreatic adenocarcinoma: a mini review for surgeons (Q48248436) (← links)
- MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer (Q49335779) (← links)